Sinusitis and upper respiratory tract diseases may increase the risk for rheumatoid arthritisNovember 30, 2021Rheumatoid Arthritis
Similar long-term safety/tolerability of filgotinib 100 mg and 200 mg in moderate-to-severe RANovember 30, 2021Rheumatoid Arthritis
Obesity, depression, anxiety, and illness beliefs influence remission, pain, and fatigue in RANovember 30, 2021Rheumatoid Arthritis
Certolizumab seems effective as monotherapy in RA patients with failure to csDMARDsNovember 30, 2021Rheumatoid Arthritis
Baricitinib demonstrates consistent long-term safety profile in RANovember 30, 2021Rheumatoid Arthritis
RA: bDMARD monotherapy may accelerate radiographic progression of preexisting distal hand osteoarthritisNovember 30, 2021Rheumatoid Arthritis
No risk of increased flare after 2 doses of COVID-19 vaccination in RANovember 30, 2021Rheumatoid Arthritis
Rheumatology NewsFauci: Omicron ‘very different from other variants’November 30, 2021COVID-19 Updates
Rheumatology NewsFDA panel backs first pill for COVID-19 by a small marginNovember 30, 2021COVID-19 Updates
Rheumatology NewsMerck’s COVID-19 pill may be less effective than first hopedNovember 30, 2021COVID-19 Updates
Rheumatology NewsDid prior authorization refusals lead to this patient’s death?November 29, 2021Business of MedicineMixed Topics
Rheumatology NewsFueling an ‘already raging fire’: Fifth COVID surge approachesNovember 24, 2021COVID-19 Updates
Rheumatology NewsValidity of commercial serologic tests for dermatomyositis still questionableNovember 24, 2021Lupus & Connective Tissue Diseases
Rheumatology NewsAxial spondyloarthritis survey raises importance of discussing treatment changesNovember 24, 2021SpondyloarthropathiesAnkylosing spondylitis
